Paper41775697
Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation.
Zeng F and 6 others. Cell Death Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation. Papers, record 41775697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41775697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transcriptional factor ZMYM3 promotes hepatocellular carcinoma metastasis by upregulating CTTN and inducing invadopodia formation.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Neoplasms | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Podosomes | Major topic |
| Cortactin | Major topic |
| Transcription Factors | Major topic |
| Humans | |
| Gene Expression Regulation, Neoplastic | |
| Animals | |
| Up-Regulation | |
| Cell Line, Tumor | |
| Epithelial-Mesenchymal Transition | |
| Neoplasm Metastasis | |
| Neoplasm Invasiveness | |
| Cell Proliferation | |
| Male | |
| Female | |
| Cell Movement | |
| Mice, Nude | |
| Prognosis | |
| Mice |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82273154 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 2023A1515012541 | Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) | PubMed | ||
| 2025A04J5148 | Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality) | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38682195 | CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. | Front Biosci (Landmark Ed) | 2024 | https://conductscience.org/library/papers/38682195 | PubMed |
| 2 | 15464244 | Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. | J Hepatol | 2004 | https://conductscience.org/library/papers/15464244 | PubMed |
| 3 | 37440829 | Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review. | Chin J Cancer Res | 2023 | https://conductscience.org/library/papers/37440829 | PubMed |
| 4 | 23843616 | Signaling inputs to invadopodia and podosomes. | J Cell Sci | 2013 | https://conductscience.org/library/papers/23843616 | PubMed |
| 5 | 14977600 | The role of dynamin in the assembly and function of podosomes and invadopodia. | Front Biosci | 2004 | https://conductscience.org/library/papers/14977600 | PubMed |
| 6 | 34876482 | Syntaxin4-Munc18c Interaction Promotes Breast Tumor Invasion and Metastasis by Regulating MT1-MMP Trafficking. | Mol Cancer Res | 2022 | https://conductscience.org/library/papers/34876482 | PubMed |
| 7 | 23518204 | Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma. | World J Surg Oncol | 2013 | https://conductscience.org/library/papers/23518204 | PubMed |
| 8 | 29172953 | Cortactin function in invadopodia. | Small GTPases | 2020 | https://conductscience.org/library/papers/29172953 | PubMed |
| 9 | 24305552 | Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition. | J Cell Mol Med | 2014 | https://conductscience.org/library/papers/24305552 | PubMed |
| 10 | 38098337 | POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38098337 | PubMed |
| 11 | 33171811 | Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33171811 | PubMed |
| 12 | 34194553 | Curcumin inhibits the viability, migration and invasion of papillary thyroid cancer cells by regulating the miR-301a-3p/STAT3 axis. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34194553 | PubMed |
| 13 | 35008569 | Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008569 | PubMed |
| 14 | 39696702 | NOX proteins and ROS generation: role in invadopodia formation and cancer cell invasion. | Biol Res | 2024 | https://conductscience.org/library/papers/39696702 | PubMed |
| 15 | 38436249 | Simultaneous Visualization and Depletion of Peroxynitrite by a Simple Aggregation-Induced Emission Nanoprobe for Preventing Breast Cancer Metastasis after Surgery. | Anal Chem | 2024 | https://conductscience.org/library/papers/38436249 | PubMed |
| 16 | 34004332 | Focal adhesion dynamics in cellular function and disease. | Cell Signal | 2021 | https://conductscience.org/library/papers/34004332 | PubMed |
| 17 | 38028589 | Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma. | Front Genet | 2023 | https://conductscience.org/library/papers/38028589 | PubMed |
| 18 | 28242625 | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | Genes Dev | 2017 | https://conductscience.org/library/papers/28242625 | PubMed |
| 19 | 38123132 | Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells. | Ann Hepatol | 2024 | https://conductscience.org/library/papers/38123132 | PubMed |
| 20 | 31401293 | Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/31401293 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTTN | 2017 | PubTator's text mining | https://conductscience.org/library/genes/2017 | NCBI Gene |
| ZMYM3 | 9203 | PubTator's text mining | https://conductscience.org/library/genes/9203 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41775697
GET https://conductscience.org/api/papers/v1/41775697/references?page=2